newsfilter
← Latest News
Business Wire·

Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of an upsized